COVID-19 Vaccines For 2022

Authored by
Staff
Last reviewed
May 12, 2022

COVID-19 Vaccines For 2022

Globally, innovative platforms such as DNA, mRNA, virus-like particles, viral vector, recombinant protein, live attenuated and inactivated virus approaches have developed COVID-19 vaccines.

On August 23, 2021, the U.S. Food and Drug Administration (FDA) Authorized the Pfizer-BioNTech mRNA Comirnaty vaccine and Approved the SpikeVax from Moderna, Inc. in 2022.

The Janssen COVID-19 vaccine remains Authorized for use in the U.S. as of April 2022.

The European Medicines Agency has Authorized (5) COVID-19 vaccines. Furthermore, the WHO has Listed ten COVID-19 vaccines. And GAVI recently reported over (100) COVID-19 vaccine candidates underwent clinical trials.

Additional vaccine news is published at PrecisionVaccinations.com/vaccines.

 

Note: Content sources on this webpage include, but are not limited to, the WHO, the CDC, industry studies, and clinicalTrials.gov. The content was Fact-Checked by healthcare professionals.